- View Curriculum Vitae
Adil E. Shamoo
Biochemistry and Molecular Biology
Epidemiology & Public Health
108 N. Greene St.,
Dr. Shamoo is a professor and former chairman of the Department of Biochemistry and Molecular Biology with a secondary appointment to the Department of Epidemiology and Preventive Medicine. He served on Defense Health Board (DHB) as Bush and Obama appointee, and currently serving a four year term appointment by Secretary Hagel as the chair of the Medical Ethics Subcommittee of the DHB. Dr. Shamoo is an Associate Fellow at the Institute for Policy Studies and senior analyst for Foreign Policy in Focus. In 1988, he founded and is the Editor-in-Chief of the journal, Accountability in Research. He also served in many other boards.
Writing often in newspapers and websites on ethics and public policy, Dr. Shamoo’s commentaries have frequently appeared in The Baltimore Sun and in Foreign Policy in Focus among many others. He is a blogger for the Huffington Post. Dr. Shamoo has been cited and has appeared many times in the media.
Shamoo was a Clinton appointee member of the National Human Research Protections Advisory Committee (NHRPAC). He has chaired twelve international conferences on ethical issues and testified before Congressional Committees and the National Bioethics Advisory Commission. Since 1994, Shamoo has been teaching a graduate course on, "Responsible Conduct of Research". He chaired the Ethics and Regulatory Forum of the Association of Clinical Research Professionals (ACRP). In 1995, he co-founded the human rights organization, Citizens for Responsible Care and Research (CIRCARE). He served on 2006 on Maryland Governor O’Malley’s Task Force on Higher Education.
Dr. Shamoo has lectured over 300 times worldwide on topics ranging from issues in ethics, science and public policy. He has held visiting professorships at notable institutions, including Sarah Lawrence College and the Institute for Political Studies in Paris, France and L'Aquila University, Italy.
Dr. Shamoo has written over 300 articles and has authored, co-authored, or edited seventeen books, including his textbook , Responsible Conduct of Research (with David Resnik, 2003, 2009, and 2015); Ethics of the Use of Human Subjects in Research (with Felix Gyi, 2002). His most recent book (2012) is entitled: Equal Worth – When Humanity Will Have Peace.
Dr. Shamoo has held full-time faculty appointments at NIH, University of Rochester School of Medicine & Dentistry, Max-Planck Institute for Biophysics, Frankfort, West Germany, Mount Sinai School of Medicine of the City University of New York, and University of Louisville.
Bioethics and Responsible Conduct of Research
- Shamoo, A. E., and Resnik, D. B. (2015), Third Edition “Responsible Conduct of Research”, pp. 1-346, 2015, Oxford University Press. Same as # 16.
- Borenstein, J., and Shamoo, A. E., 2015. Rethinking Authorship in the Era of Collaborative Research, Accountability in Research, 22 (5):….., 2015.
- Shamoo, A. E., 2013. Data Audit as a Way to Prevent/Contain Misconduct, Accountability in Research, 20:369-379, 2013.
- Shamoo, A. E., (2012), Equal Worth – When Humanity Will Have Peace, University Press of America, Lanham.
- Shamoo, A. E., and Ayyub, Bilal, M., 2011. Benefit/Risk Estimates in Clinical Trials, Drug Information Journal, 45, 669-685, 2011.
- Resnik, D. B., and Shamoo, A. E., (2011), The Singapore Statement on Research Integrity, Accountability in Research, 18:2, 71-75, 2011.
- Shamoo, A. E., 2010. Ethical and Regulatory Challenges in Psychophysiology and Neuroscience-Based Technology for Determining Behavior, Accountability in Research, 17:8-29, 2010
- Shamoo, A. E., 2008. "The Myth of Equipoise in Phase 1 Clinical Trials", Medscape J Med. 2008;10(11):254. 2008 Medscape, Posted 11/05/2008
- Amin, S. B., McDermott, M. P., and Shamoo, A. E. 2008. "Clinical Trials of Drugs Used Off-Label in Neonates: Ethical Issues and Alternative Study Designs", Accountability in Research, 15:168-187.
- Shamoo, A. E. and Katzel, L.I., 2008. "How Should Adverse Events Be Reported in US Clinical Trials?: Ethical Consideration", Clinical Pharmacology & Therapeutics, 27 Feb 2008), doi: 10.1038/clpt.2008.14, Ethics
- Shamoo, A. E., and Schwartz, J. 2007. "Universal and Uniform Protections of Human Subjects in Research", American Journal of Bioethics, 7(12): 7-9.
- Shamoo, A. E., and Woeckner, E. 2007. "Ethical Flaws in the TeGenero Trial", The American Journal of Bioethics, 7:2, 90 - 92
- Silverman, H. et al (Shamoo, A. E.), 2006. "Enhancing Research Ethics Committees in Egypt - Guidelines for Standard Operating Procedures", Monitor, Dec, 2005, 49 - 52, and Appendix, A1 - A17.
- Shamoo, A. E., and Resnik, D. B., (2006), "Ethical Issues for Clinical Research Managers", Drug Information Journal, 40: 371-383.
- Shamoo, A. E. (2006), "Letter to the Editor: Emergency Research Consent Waiver - A Proper Way", American Journal of Bioethics, 6(4): W48 - W51.
- Shamoo, A. E. and Resnik, D. B. (2006), " Strategies to Minimize Risks and Exploitation in Phase One Trials on Healthy Subjects", American Journal of Bioethics, 6(3): W1 - W13.
- Shamoo, A. E. (2005), "Accountability in Research," In: Encyclopedia of Science, Technology, and Ethics, edited by Carl Mitcham, Thompson - Gale Company.
- Shamoo, A. E. (June, 2005), "Debating Moral Issues in Developing Countries", Applied Clinical Trials (actmagazine.com), 14(6):86-96.
- Shamoo, A. E. (2005), "The Need for Better Reporting of Adverse Events for Human Subjects in Research", DIA Today, April 2005, Volume 5, Issue 2, p. 18, 20.
- Resnik, D. B. and Shamoo, A. E., (2005) " Bioterrrorism and the Responsible Conduct of Research", Commentary, Drug Development Research, 63:121-133.
- Shamoo, A. E. and Cole, J. (2004), "Ethics of Genetic Modification of Behaviour", Accountability in Research, 11:201-214.
- Shamoo, A. E. and Strause, L. (2004) "Closing the Gap in Regulations for the Protection of Human subjects in Research", Monitor, Spring 2004, chosen as cover story.
- Shamoo, A. E. and Moreno, J. (2004) "A Response to Commentators on "Ethics of Research Involving Mandatory Drug Testing of High School Athletes in Oregon", American Journal of Bioethics 4:W 29.
- Shamoo, A.E. and Moreno, J. (2004), "Ethics of Research Involving Mandatory Drug Testing of High School Athletes in Oregon," American Journal of Bioethics 4:25-31, (Chosen as a Target Article with 13 commentaries).
- Shamoo, A.E., and Cole, J.W. (2004), "Fear of Influence - Conflict of Interest in Biomedical and Genetic Research," In: GenWatch 13:12-13, July-August (Both in the magazine and website).
- Shamoo, A.E., and Campbell, J. D., (2003), "The Use of Experimental Drugs During National Crises," Accountability in Research, 10:69-84, 2003.
- Shamoo, A.E., and Tauer, C.A. (2002), "Ethically Questionable Research with Children: The Fenfluramine Study," Accountability in Research, 9:143-166,2002.
- Resnik, D., and Shamoo, A.E., 2002. Conflict of Interest and the university, Accountability in Research, 9: 45- 64.
- Shamoo, A.E. (2002), "Ethically Questionable Research with Children. The Kennedy Krieger Lead Abatement Study," Accountability in Research, 9:167-175, 2002.
- Shamoo, A.E. (2001), "Adverse Events Reporting - The Tip of an Iceberg," Accountability in Research, 8:197-218.
- Shamoo, A. E. and Cheryl Dunigan (2000), "Ethics in Research", Experimental Biology and Medicine 224:205-210.
- Sharav, V. H., and Shamoo, A. E. (2000), "Are Experiments That Chemically Induce Psychosis In Patients Ethical?", BioLaw, II, No.1: S1-S36.
- Shamoo, A.E. (1999), "Critique of the Recommendations of the National Bioethics Advisory Commission's Report on Research Involving Persons with Mental Disorders That May Affect Decisionmaking Capacity," BioLaw II, Nos. 9 & 10:S439-S444.